Mechanistic Study of NAT10 Deficiency Enhancing Olaparib Sensitivity in Triple Negative Breast Cancer by Inhibiting RAD51 ac4C Modification(KTD107-4.1)
Mechanistic Study of NAT10 Deficiency Enhancing Olaparib Sensitivity in Triple Negative Breast Cancer by Inhibiting RAD51 ac4C Modification(KTD107-4.1)